Skip to main content

Nonprofit drug developer in uphill battle against Trump administration contraception rule change

Medicines360 is pushing its low-cost IUD into African nations while its U.S. market faces pressure from a potential change in rules for a federal program.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.